ArticleJournal of clinical medicine2026
Refractory Thrombocytopenia in TP53-Aberrant Chronic Lymphocytic Leukemia: A Multimechanistic Case with Response to Idelalisib and Romiplostim.
Serkan Guven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.